Conexiant

What Conexiant does

Conexiant is a Connecticut-based healthcare media and intelligence company that connects medical associations, pharmaceutical and life science brands, and verified healthcare professionals (HCPs) through an integrated platform of digital media, events, learning, and publications. The company operates as the outsourced media business partner for more than 200 medical associations and societies — including ASCO, ADA, AGA, NCCN, and APSHO — managing ad sales, content production, publishing, learning management, and CE/CME-accredited events under each association's brand. On the demand side, it serves more than 400 life science and consumer health clients, including all top 10 pharmaceutical firms by 2025 revenue, giving brands access to a network of 3.1 million verified HCPs across 29 therapeutic areas and 250+ publications spanning oncology, ophthalmology, optometry, dentistry, and European science titles. The platform reaches 50% of the U.S. News & World Report Best Hospitals Honor Roll and generates approximately 43 million HCP engagements per month at open rates 2x–10x above healthcare-industry benchmarks.

Core technology centers on (1) the MDspire AI platform, which uses a proprietary vector database, fine-tuned large language models, and a retrieval-augmented generation framework with human clinical expert review to transform clinical content from societies, journals, and hospitals into microcontent formats; (2) the mDNA behavioral analytics platform, which tracks HCP-level audience behavior across the network; (3) the MD-ID targeting platform, which turns behavioral signals into physician-level brand engagement; and (4) the OPUS DX virtual and hybrid event platform inherited from the 2022 acquisition of Digitell. Conexiant is a 424 Capital portfolio company that consolidated Digitell, AEGIS Dental Network, PentaVision, Harborside, and Texere Publishing under the Conexiant brand in May 2024. Its revenue model blends five streams: advertising and content monetization, recurring publication services, event production and management, managed digital platform services, and sponsored virtual events. Go-to-market is enterprise field sales backed by association channel partnerships, with AI-focused specialty platforms (ASCO AI in Oncology, AACE Endocrine AI) launching in 2026 as a new product surface. The company does not disclose pricing publicly and operates on quote-based, custom-solution engagements.

Name

Conexiant

Legal name

Conexiant

Website

https://conexiantsolutions.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Conexiant is a healthcare media and intelligence company that operates digital publishing, events, and AI platforms on behalf of 200+ medical associations and 400+ life science clients, reaching 3.1 million verified healthcare professionals across 29 therapeutic areas.

Ownership category

akta.pro rank

Headquarters

HQ city

Huntington

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Advertising & Content Monetization: Conexiant runs entire media businesses for associations, managing ad sales operations that generate ongoing non-dues revenue. Places branded content across digital, print, and live experiences. Generates revenue from 300+ advertisers in their network, including programmatic advertising, banner ads, display ads, and sponsored content.
2. Publication Services: Publishing services for medical associations and societies including flagship news publications, digital and print advertising, sponsorship sales, and operations. Partners manage print and digital advertising sales, sponsored content, and classified listings.
3. Event Production & Management: End-to-end event production and management services including virtual, hybrid, and in-person events. Includes CE/CME-accredited conferences like JADPRO Live with 1,600+ attendees. Generates revenue from exhibit halls, sponsorships, and registration fees.
4. Digital Solutions & Technology: Provides technology platforms including MDspire, MD-ID targeting, and analytics tools. Revenue from programmatic advertising, triggered marketing campaigns, clinical content programs, customized engagement solutions, and learning management systems.
5. Sponsored Webcasts & Webinars: Sponsored webcasts, panel discussions, roundtables, and digital symposiums for brands to showcase expertise and generate marketing qualified leads.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Conexiant operates a healthcare intelligence network that provides digital advertising, custom content production, AI-powered engagement platforms, event technology, and full-service media operations on behalf of medical associations and pharmaceutical/life science brands. The company distributes clinical content across 250+ publications, 200+ association-branded properties, and proprietary platforms (MDspire, mDNA, MD-ID, OPUS DX) to reach 3.1 million verified healthcare professionals across 29 therapeutic areas. Conexiant monetizes association content through advertising sales, sponsored programs, virtual and in-person events, and physician-level behavioral targeting.

Product overview

Conexiant is a healthcare intelligence company providing an integrated platform of digital solutions, events, learning, and publications that connects medical associations, pharmaceutical brands, and healthcare professionals. The product portfolio centers on MDspire, an AI-powered engagement platform using proprietary vector database, fine-tuned LLMs, and RAG framework to transform trusted medical content into snackable microcontent with human clinical oversight. Key platforms include ASCO AI in Oncology (AI-focused cancer care platform with ASCO) and AACE Endocrine AI (AI-focused endocrine care platform with AACE). The company operates 250+ publications across oncology, ophthalmology, optometry, dentistry, and European science titles including The ASCO Post, JADPRO, JNCCN, Journal of Clinical Oncology, Inside Dentistry, Compendium, Contact Lens Spectrum, Eyecare Business, The Ophthalmologist, The Pathologist, and The Analytical Scientist. Content services include digital advertising, webinars/virtual events, video production, social media, and custom content. Event capabilities span OPUS DX virtual/hybrid event platform and annual conferences including JADPRO Live. The proprietary mDNA audience intelligence platform and MD-ID targeting system power audience engagement across 3.1 million verified HCPs.

Differentiator

Problem solved

Functional benefit

Brands

• MDspire: AI-powered discovery and engagement platform transforming how physicians, researchers, and healthcare professionals consume clinical knowledge. Uses proprietary AI backbone with vector database, fine-tuned models, and retrieval-augmented generation (RAG) framework with human clinical oversight.

Products and services

• MDspire AI-powered discovery and engagement platform that transforms content from clinical societies, peer-reviewed journals, and hospital systems into snackable microcontent (summaries, Q&A, reports, clinical takeaways). Combines a proprietary AI backbone (vector database, fine-tuned LLMs, RAG framework) with human and clinical expert review. Built for physicians, researchers, and HCPs.
• ASCO AI in Oncology Premium digital destination developed with ASCO delivering curated content and education on AI in cancer care. Connects pharma, biotech, and AI technology companies with oncology professionals through expert perspectives on AI applications in diagnostics, workflows, and treatment pathways.
• AACE Endocrine AI Digital hub developed with the American Association of Clinical Endocrinology focused on real-world AI impact in endocrine care. Combines AACE's clinical authority with Conexiant's media expertise to engage endocrinologists with expert insights, research, and applications in predictive analytics, clinical decision support, population health management, and precision treatment.
• OPUS DX Proprietary virtual and hybrid event platform developed by Digitell (acquired 2022) for hosting virtual/hybrid events, webinars, and on-demand educational sessions. Features live streaming, content syndication, on-demand digital libraries, online CE testing, and conference evaluations.
• mDNA Platform Proprietary AI-powered audience intelligence platform providing perspectives on HCP behavior and clinical impact. Delivers behavioral tracking and analytics insights into verified HCP audience engagement across the network.
• MD-ID Targeting Platform Proprietary physician-level targeting platform that tracks HCP engagement and digital behaviors across geographies, specialties, and behaviors to drive measurable brand engagement and inform campaign segmentation.
• Digital Advertising Solutions Full-service digital advertising including banner ads, display ads, programmatic advertising, and email campaigns with precision behavioral and contextual targeting for healthcare and science audiences across 200+ healthcare websites.
• Webinars & Virtual Events End-to-end virtual event production services including sponsored webcasts, panel discussions, roundtables, and digital symposiums, with full support from concepting to execution.
• Video Production Video content production including branded video content, KOL interviews, live-streamed video, and product explainers for technical and clinical audiences.
• Social Media Solutions Social media services including branded reels, sponsored content, boosted posts, and channel takeovers for healthcare and science brands.
• Custom Content Custom content development including thought leadership articles, executive summaries, eBooks, and branded content for healthcare and science professionals.
• JADPRO Live Premier annual educational conference for oncology advanced practitioners, organized in conjunction with APSHO. Features 25+ CE/CME-accredited sessions, networking opportunities, exhibits, and multimodal therapy tracks; 1,600+ attendees.
• Publication Portfolio (250+ clinical publications) Portfolio of 250+ clinical publications across oncology, ophthalmology, optometry, dentistry, and European science markets. Key titles include The ASCO Post, JNCCN, Journal of Clinical Oncology, JADPRO, Inside Dentistry, Compendium of Continuing Education in Dentistry, Contact Lens Spectrum, The Ophthalmologist, and The Pathologist. Publications generate advertising, sponsorship, and CE-accredited content revenue.

Quantifiable outcome

• 10x revenue growth in online sales for American Nephrology Nurses Association (ANNA) since 2008
• +7 more outcomes

Named customers38 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered flagship, core and minor.

• American Association of Clinical Endocrinology (AACE)flagshipStrategic or Co-development Partner · 15 April 2026Launched AACE Endocrine AI, a digital hub focused on real-world impact of AI in endocrine care. Combines AACE's clinical authority with Conexiant's healthcare media expertise to engage endocrinologists seeking guidance on AI integration. Offers advanced targeting capabilities for advertisers.
• American Society of Clinical Oncology (ASCO)flagshipStrategic or Co-development Partner · 10 February 2026Launched ASCO AI in Oncology, a premium digital destination connecting pharmaceutical, biotech, and AI technology companies with oncology professionals exploring AI in cancer care. Platform offers curated content, education, and expert perspectives. Built on 15+ years of collaboration producing trusted oncology news including early AI coverage.
• American Gastroenterological Association (AGA)coreStrategic or Co-development Partner · 8 October 2025Strategic partnership to publish AGA's flagship news publication GI & Hepatology News. Conexiant manages digital and print advertising, sponsorship sales, and operations. Transition effective January 1, 2026 with first Conexiant-published edition shortly thereafter.
• Greater New York Dental Meeting (GNYDM)minorGTM or Marketing Partner · 6 October 2025Partnership to present 2025 Product Solutions Center, a free continuing education series highlighting latest dental innovations. Program runs November 30 - December 3, 2025 during 101st annual GNYDM with up to 4 CE credits per day.
• ElseviercoreStrategic or Co-development Partner · 11 March 2025Partnership to deliver advertising, content solutions, and advanced audience-targeting to 100+ global societies and associations covering 25+ core specialties. Effective April 1, 2025, Conexiant manages print/digital advertising sales, sponsored content, classified listings, programmatic advertising, triggered marketing campaigns, and clinical content programs.
• Texere Publishing Ltd.coreOthers · 12 June 2024Acquisition of Texere Publishing Ltd., a B2B media company with strong presence in UK, Europe, and US. Expands Conexiant's total reach to over 3 million HCPs across 16 adult specialties and 10 pediatric specialties. Texere specializes in scientific and healthcare markets content.
• American Dental Association (ADA)coreStrategic or Co-development Partner · 23 August 2023Expanded partnership since 2021 to deliver advanced educational resources, engagement tools, and publishing services for dental professionals. Leverages Conexiant's audience engagement platform and publishing infrastructure for ADA's Learning Management System, Store, and ADA News publication.
• HarborsidecoreOthers · 12 October 2022Acquisition of Harborside, a healthcare media company specializing in oncology, hematology, and other therapeutic areas. Expanded reach to over 2.8 million HCPs across 16 adult and 10 pediatric specialties. Harborside provides advertising services for The ASCO Post, JNCCN, JCO publications, and ASCO's full publication suite.
• PentaVisioncoreOthers · 29 August 2022Acquisition of PentaVision, a media company specializing in ophthalmology, optometry, and opticianry. Adds hundreds of doctors, writers, speakers, and editors with track record of innovation. Produces six magazines, two live conferences, multiple events, and 100+ content projects annually.
• AEGIS Dental NetworkcoreOthers · 18 August 2022Acquisition of AEGIS Dental Network, a dental media company expanding Conexiant's audience with 400k dental clinicians to existing 1.7M+ physicians. AEGIS provides content for clinicians, technicians, hygienists, assistants, and students.
• Digitell, Inc.minorOthers · 10 March 2022Acquisition of Digitell, Inc., a virtual event and digital content provider specializing in hybrid and virtual events. Digitell developed OPUS DX platform for designing, building, and delivering virtual/hybrid events, webinars, and on-demand educational sessions.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Definitive Healthcare: Public healthcare commercial intelligence and analytics platform serving life science customers with HCP and account-level data. Adjacent competitor in the pharma-analytics and targeting stack that increasingly overlaps with Conexiant's mDNA/MD-ID offerings.
• Sermo: Physician social network monetized through market research and HCP engagement campaigns. Emerging alternative channel for pharma marketing budgets that could overlap with Conexiant's community and audience-targeting offerings.

Broad incumbents

• Wolters Kluwer Health: Major medical publisher and clinical decision support vendor with substantial pharma-sponsored content and society partnerships. Competes for the same association publishing and brand-engagement dollars at large accounts.
• Elsevier (RELX): Global scientific and medical publisher that is also a Conexiant partner (covers 100+ societies). Comparable in medical society publishing and pharma-funded content, but operates at much larger scale across the full research lifecycle.
• Healthline Media: Large consumer health content publisher with pharma and consumer health brand advertising. Broad incumbent with overlapping advertiser base (top 10 pharma) but consumer rather than HCP audience focus.
• Informa Markets (Informa Pharma): Large B2B events and media group with healthcare conferences and intelligence offerings. Comparable in operating medical association media businesses and life science events at global scale.

Direct peers

• Medscape (WebMD Health): Largest physician-education and pharma marketing platform, offering CME, news, and endemic advertising. Direct peer for branded-content and display spend targeting office-based and hospital-based HCPs.
• MJH Life Sciences: Private, PE-backed healthcare B2B media company spanning specialty publications, events, and HCP marketing. Closest structural analog — vertically integrated society media services built through acquisition, similar to Conexiant's roll-up strategy.
• PatientPoint: Endemic point-of-care health media and HCP marketing company. Comparable in serving life science brand budgets across healthcare touchpoints with exclusive inventory and physician engagement.
• Doximity: Public physician social network with verified HCP identity, endemic pharma advertising, and increasingly AI-driven workflow tools. Most direct competitor to Conexiant for verified-HCP marketing budgets at the largest pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/conexiant
• YouTubeyoutube.com/@conexiantnews
• Facebookfacebook.com/ConexiantNews
• LinkedInlinkedin.com/company/conexiant

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conexiant